The health ministry has approved the Pfizer/BioNTech Covid-19 vaccine for domestic emergency use.
Developed in partnership between Germany company BioNTech and US firm Pfizer, this is the fourth vaccine to receive such authorisation, following Oxford/AstraZeneca, Sputnik V, and Sinopharm’s Vero Cell.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!